Application status of endoscopic anti-reflux mucosal interventions in the treatment of gastroesophageal reflux disease

Table 7 Incidence of postoperative dysphagia and related complications following anti-reflux mucosal ablation

Ref.	Year	Intervention	Cases	Incidence of adverse events (%)
				Stenosis or dysphagia	Relief after dilatation	Bleeding	Perforation
Inoue et al[6]	2014	ARMS	10	20.0	Yes	0.0	0.0
He et al[8]	2022	L-ARMS	69	65.2	No	0.0	0.0
Gao et al[9]	2023	ARMS	20	0.0	NA	0.0	0.0
Sumi et al[10]	2021	ARMS	88	15.9	Yes	2.3	1.1
Wong et al[11]	2020	ARMS	33	9.1	Yes	3.0	0.0
Sui et al[12]	2022	ARMS	39	2.6	Yes	0.0	0.0
Sumi et al[14]	2024	ARMS	36	22.2	Yes	0.0	0.0
Yang et al[17]	2021	ARMS	39	23.1	Yes	2.6	0.0
Chou et al[22]	2022	ARMS	11	0.0	NA	0.0	0.0
Klimczak and Strzelczyk[24]	2023	ARMS-C	115	0.0	NA	0.0	0.0
Monino et al[32]	2020	ARMS-b	21	14.3	Yes	4.8	0.0
Patil et al[33]	2020	ARMS-C	33	6.1	Yes	0.0	0.0
Patil et al[33]	2020	ARMS	62	8.1	Yes	0.0	3.2
Hedberg et al[35]	2019	ARMS-b	19	15.8	Yes	5.3	0.0
Laquière et al[37]	2022	ARMS	13	7.7	Yes	15.4	0.0
Hu et al[38]	2023	ARMS	12	25.0	No	0.0	0.0
Average				14.69		2.09	0.27

ARMS: Anti-reflux mucosectomy; L-ARMS: Ligation-assisted anti-reflux mucosectomy; ARMS-b: Anti-reflux mucosectomy using band ligation; ARMS-C: Anti-reflux mucosectomy with cap-assisted; NA: Not available.